<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04456166</url>
  </required_header>
  <id_info>
    <org_study_id>20030471108</org_study_id>
    <nct_id>NCT04456166</nct_id>
  </id_info>
  <brief_title>Safety of Preoperative Carbohydrate Loading in Diabetic Patients</brief_title>
  <acronym>NoNPO</acronym>
  <official_title>Safety of Preoperative Carbohydrate Loading in Diabetic Patients Undergoing General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the safety of preoperative carbohydrate loading
      in diabetic patients undergoing general anesthesia
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 22, 2020</start_date>
  <completion_date type="Anticipated">May 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 25, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of gastric ultrasonography score as low risk (grade 0 or 1)</measure>
    <time_frame>30 minutes after intubation</time_frame>
    <description>Ultrasound assessment of gastric volume by gastroscopic examination.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gastric volume</measure>
    <time_frame>30 minutes after intubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood sugar test</measure>
    <time_frame>30 minutes after intubation and 30 minutes after extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of insulin bolus injection</measure>
    <time_frame>during operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of insulin bolus injection</measure>
    <time_frame>up to 30 minutes after extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction scale of patients</measure>
    <time_frame>up to 30 minutes after extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of nausea and vomiting</measure>
    <time_frame>up to 30 minutes after extubation</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Carbohydrate Intolerance</condition>
  <condition>Diabetes Mellitus Type 2</condition>
  <arm_group>
    <arm_group_label>Patient who received carbohydrate loading</arm_group_label>
    <description>Patients with diabetes mellitus type 2 who are planned to receive a carbohydrate beverage (400 ml (12.8% carbohydrates, 50 kcal/100 ml; Nucare NONPO Ⓡ , Daesang Wellife, Korea) before the operation and up to 2 hours before the induction of anesthesia outside this clinical study setting</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>noNPO</intervention_name>
    <description>Patients with diabetes mellitus type 2 who are planned to receive a carbohydrate beverage (400 ml (12.8% carbohydrates, 50 kcal/100 ml; Nucare NONPO Ⓡ , Daesang Wellife, Korea) before the operation and up to 2 hours before the induction of anesthesia outside this clinical study setting will be asked to be enrolled into the study.
Before induction of general anesthesia, all patients were evaluated the gastric volume under ultrasonography.</description>
    <arm_group_label>Patient who received carbohydrate loading</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 years of age who are scheduled to undergo general anesthesia are subject
        to preoperative carbohydrodritate loading and diagnosed with type 2 diabetes taking oral
        hypoglycemic agents
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective surgery

          -  Type 2 diabetes mellitus on oral hypoglycemic agents

          -  American Society of Anesthesiologists physical status 2 or 3

          -  Ages 18 or more

          -  Approve to participate

        Exclusion Criteria:

          -  Ambulatory surgery

          -  BMI &gt;35

          -  History of gastric or esophagus surgery

          -  History of GERD, dyspepesia or

          -  Anticipated difficult intubation (previous III or more Cormack and Lehane's grade,
             Mallamgrade, Mallampati scpati scoreore III or moreIII or more,
             propro/retro/retrognathism, gnathism, thyromental distance&lt;6.5cm, thyromental
             distance&lt;6.5cm, limited mouth openinglimited mouth opening)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Susie Yoon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susie Yoon, MD</last_name>
    <phone>+82-2072-7361</phone>
    <email>susiey87@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bo Rim Kim, MD</last_name>
    <phone>+82-2072-7361</phone>
    <email>petitbelle22@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Jongnogu</state>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susie Yoon, MD</last_name>
      <phone>+82-2072-7361</phone>
      <email>susiey87@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Bo Rim Kim, MD</last_name>
      <phone>+82-2072-7361</phone>
      <email>petitbelle22@naver.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 25, 2020</study_first_submitted>
  <study_first_submitted_qc>June 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2020</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Susie Yoon</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Carbohydrate Intolerance</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Diabetes Mellitus, Type 2</keyword>
  <keyword>Carbohydrate loading</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

